Dr. Pliskin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3301 Mercy Health Blvd
Suite 525
Cincinnati, OH 45211Phone+1 513-841-7700Fax+1 513-841-7701
Education & Training
- Tripler Army Medical CenterResidency, Urology, 1985 - 1989
- Tripler Army Medical CenterInternship, Transitional Year, 1983 - 1984
- Philadelphia College of Osteopathic MedicineClass of 1983
Certifications & Licensure
- OH State License 1991 - 2026
- HI State License 1987 - 1992
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification meridianEMR, meridianEMR, Inc., 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- Effect of crossover from placebo to darolutamide on overall survival in men with non-metastatic prostate cancer: sensitivity analyses from the randomised phase 3 ARAMI...Neal D Shore, Karim Fizazi, Teuvo L J Tammela, Murilo Luz, Manuel Philco Salas
European Journal of Cancer. 2023-09-17 - 2 citationsIsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study.Jason M Scovell, Mark Stovsky, Alan Partin, Yair Lotan, Jack Baniel
Urology. 2023-05-01 - 7 citationsClinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study.Eric A Klein, Alan Partin, Yair Lotan, Jack Baniel, Martin Dineen
Urologic Oncology. 2022-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: